Lupin gets FDA nod for generic Aricept tablets
Lupin said it has received final approval from the US drug regulator to market generic Aricept tablets used for treatment of dementia. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 3, 2015 Category: Pharmaceuticals Source Type: news

Not stopping donepezil may delay nursing home admission for Alzheimer’s patients
Drug is usually discontinued as symptoms worsen due to a lack of perceived benefit and to reduce costs to NHSRelated items from OnMedicaGovernment launches major drive to tackle dementia One in three people born this year in UK will develop dementiaDementia and stroke funding remains too low, say expertsWhy don’t dementia strategies work?Right lifestyle can slow down dementia claim (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 28, 2015 Category: UK Health Source Type: news

Cheap Alzheimer's drug 'may help keep people out of care homes'
Conclusion This randomised controlled trial assessed the impact of continuing or discontinuing the Alzheimer's drug donepezil on the chances of nursing home admission in people with moderate to severe Alzheimer's. The study examined discontinuing or continuing donepezil, either alone or in combination with memantine, or switching to memantine alone. Memantine is currently licensed for the treatment of moderate to severe Alzheimer's, while donepezil is only licensed for mild to moderate forms of the disease. In this trial, people had already been taking donepezil for three to six months or more. These drugs are only given...
Source: NHS News Feed - October 27, 2015 Category: Consumer Health News Tags: Medication Mental health Neurology Older people Source Type: news

Stopping donepezil ups risk of care home admission
Withdrawing a commonly-prescribed Alzheimer’s drug in the advanced stages of the disease doubles the risk of patients moving to a nursing home within a year, according to a UK study. (Source: Nursing Times Breaking News)
Source: Nursing Times Breaking News - October 27, 2015 Category: Nursing Source Type: news

Six pence drug could keep Alzheimer's patients out of care homes
The drug donepezil helps late stage dementia patients to cope with everyday tasks like dressing and shopping (Source: Telegraph Health)
Source: Telegraph Health - October 27, 2015 Category: Consumer Health News Tags: Alzheimer's disease donepezil independent living dementia care homes Source Type: news

Investigational Drug Added to Donepezil Shows Promise in ADInvestigational Drug Added to Donepezil Shows Promise in AD
Adding 5-HT6 receptor antagonist RVT-101 to standard therapy with donepezil in adults with mild to moderate Alzheimer's disease resulted in improved cognition and function. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - July 24, 2015 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Donepezil Add-On Promising in Completer Analysis
(MedPage Today) -- Serotonin modulator slows but doesn't stop cognitive decline in phase II re-analysis. (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - July 22, 2015 Category: Psychiatry Source Type: news

Alzheimer's Society comment on potential new symptomatic therapy for Alzheimer's disease
Results from a clinical trial reported at the Alzheimer's Association International Conference 2015 today (Wednesday 22 July) have shown positive evidence in boosting the efficacy of donepezil, also known as Aricept, which is used in mild to moderate Alzheimer's disease to relieve some symptoms of the condition. (Source: Alzheimers Society)
Source: Alzheimers Society - July 22, 2015 Category: Geriatrics Source Type: news

Donepezil Helps Some Patients Treated With Brain IrradiationDonepezil Helps Some Patients Treated With Brain Irradiation
Phase 3 trial results suggest that donepezil improves some aspects of cognition in patients with brain tumors treated with brain irradiation. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 30, 2015 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Experts Weigh In On The Ethics Of Using Brain-Enhancing Drugs
By: Tanya Lewis Published: March 26, 2015 08:00am ET Boosting a person's smarts through drugs or electrical or magnetic stimulation of the brain is becoming an increasingly widespread practice. Now, bioethicists are weighing in, saying that while such cognitive enhancement is neither bad nor good, it deserves more research. In the past, "there have been many arguments that suggest one should take an ethical stance for or against cognitive enhancement" of healthy individuals, said Amy Gutmann, chairwoman of the Presidential Commission for the Study of Bioethical Issues, which released the second part of a report...
Source: Science - The Huffington Post - March 27, 2015 Category: Science Source Type: news

High-Dose Donepezil: Which Patients Benefit?High-Dose Donepezil: Which Patients Benefit?
Is high-dose donepezil effective for reducing symptoms of Alzheimer disease? Medscape Internal Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 24, 2015 Category: Consumer Health News Tags: Internal Medicine Ask the Expert Source Type: news

Namzaric (Memantine/Donepezil) for the Treatment of Alzheimer's Disease
Namzaric (memantine/donepezil) is the first fixed-dose combination drug approved for the treatment of moderate and severe Alzheimer's disease in the US. (Source: Drug Development Technology)
Source: Drug Development Technology - February 17, 2015 Category: Pharmaceuticals Source Type: news

Donepezil May Slow Hippocampal Atrophy in Prodromal AD Donepezil May Slow Hippocampal Atrophy in Prodromal AD
A new study shows that donepezil slows atrophy of the hippocampus in patients with prodromal Alzheimer's disease, although this did not correlate with cognitive benefit. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - February 4, 2015 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Namzaric (Memantine Hydrochloride Extended-release and Donepezil Hydrochloride Capsules) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 2, 2015 Category: Drugs & Pharmacology Source Type: news

FDA OKs Namzaric Combo Pill for Alzheimer's DiseaseFDA OKs Namzaric Combo Pill for Alzheimer's Disease
The memantine/donepezil combination offers a once-daily fixed-dose combination of two treatments often prescribed together in one capsule. FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 27, 2014 Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news